The 5th Ophthalmic Drug Delivery Summit is where the innovators behind the next generation of ocular therapies come together to solve one critical challenge: getting the right therapy to the right place in the eye.

Hear directly from leaders at Kodiak Sciences, Re-Vana Therapeutics, Ripple Therapeutics, Eli Lilly, Genentech, Sanofi, Astellas, Apellis, Beacon Therapeutics, Kriya Therapeutics and more as they share the latest thinking on long-acting therapies, novel delivery routes, gene and cell therapy, translational science and drug-device integration.

With clinical validation and investment accelerating across the field, this industry-focused, modality and indication-agnostic meeting offers a timely opportunity to benchmark emerging technologies, learn from development successes and setbacks, and connect with the experts tackling the biggest barriers to effective ocular delivery.

Expect candid lessons, emerging strategies and cross-functional perspectives spanning delivery, formulation, devices, CMC, clinical development, regulatory strategy and commercialization.

Don’t miss the only industry-focused, modality, and indication-agnostic forum dedicated to ophthalmic drug delivery.

To know more visit: https://ter.li/4m4gw2gg